Categories: Artificial IntelligenceBioTechDrugHealthTechMedTechPlatform
Auransa is an AI-driven pharmaceutical company that develops precise medicines for patients in areas of significant unmet medical need
Investors 4
Mentions in press and media 5
| Date | Title | Description |
| 23.03.2023 | Auransa Collaborates with USC Norris Comprehensive Cancer Center to Study AU409 in Liver Cancer Clinical Trial | AU409 trial to be conducted by Dr. Anthony El-Khoueiry at the USC Norris Comprehensive Cancer Center, University of Southern California
PALO ALTO, CALIFORNIA, USA, March 23, 2023/EINPresswire.com/ -- Auransa Inc., a clinical stage drug deve... |
| 03.11.2022 | FDA Acceptance of Auransa's IND Application for AU409 for Treatment of Patients with Hepatocellular Carcinoma | First compound to enter clinical trial stage from a pipeline of research programs based upon Auransa’s proprietary AI platform
PALO ALTO, CA, UNITED STATES, November 3, 2022 /EINPresswire.com/ -- Auransa Inc., a clinical stage drug developm... |
| 09.08.2022 | POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI | POLARISqb and Auransa Partner to Tackle Women's Health Issues
Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target.
PALO ALTO, CA, DURH... |
| 02.09.2021 | Startups should look to state-of-the-art tech to tackle diseases affecting women | Shahar Keinan Contributor
Share on Twitter
Shahar Keinan, co-founder and CEO of Polaris Quantum Biotech has over 20 years of extensive experience in computational and theoretical chemistry.
Pek Lum Contributor
Share on Twitter
Pek Lum, co-f... |
| 25.06.2021 | This Startup Is Using Quantum Computing And AI To Cut Drug Discovery Time From 3 Years To 4 Months | Polaris Quantum Biotech is reinventing drug discovery, reducing the time it takes to find candidate molecules for drug development from the typical three years to just four months. As with other successful efforts to redesign established pr... |
Reviews 0
